Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from Challenger ( (AU:CGF) ) is now available.
TAL Dai-ichi Life, the Australian subsidiary of Dai-ichi Life Holdings, has received all necessary regulatory approvals for its minority investment in Challenger Limited. This acquisition will result in TAL holding a 19.9% equity interest in Challenger, potentially impacting the company’s market positioning and stakeholder interests.
The most recent analyst rating on (AU:CGF) stock is a Buy with a A$7.80 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
More about Challenger
Challenger Limited is an investment management firm dedicated to providing financial security for retirement. It operates through a fiduciary Funds Management division and an APRA-regulated Life division, with Challenger Life Company Limited being Australia’s largest provider of annuities.
Average Trading Volume: 2,819,330
Technical Sentiment Signal: Buy
Current Market Cap: A$5.65B
See more insights into CGF stock on TipRanks’ Stock Analysis page.